Logo image of SBT

Sterling Bancorp Inc (SBT) Stock Fundamental Analysis

NASDAQ:SBT - Nasdaq - US85917W1027 - Common Stock - Currency: USD

4.84  -0.04 (-0.82%)

After market: 4.88 +0.04 (+0.83%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SBT. SBT was compared to 393 industry peers in the Banks industry. The financial health of SBT is average, but there are quite some concerns on its profitability. SBT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SBT was profitable.
SBT had a positive operating cash flow in the past year.
In multiple years SBT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: SBT reported negative operating cash flow in multiple years.
SBT Yearly Net Income VS EBIT VS OCF VS FCFSBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.25%, SBT is doing worse than 85.86% of the companies in the same industry.
SBT's Return On Equity of 1.80% is on the low side compared to the rest of the industry. SBT is outperformed by 86.35% of its industry peers.
Industry RankSector Rank
ROA 0.25%
ROE 1.8%
ROIC N/A
ROA(3y)-0.06%
ROA(5y)0.06%
ROE(3y)-0.55%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
SBT Yearly ROA, ROE, ROICSBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

SBT has a Profit Margin of 10.19%. This is amonst the worse of the industry: SBT underperforms 83.62% of its industry peers.
In the last couple of years the Profit Margin of SBT has declined.
SBT does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 10.19%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-46.39%
PM growth 5Y-29.96%
GM growth 3YN/A
GM growth 5YN/A
SBT Yearly Profit, Operating, Gross MarginsSBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

4

2. Health

2.1 Basic Checks

SBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SBT has more shares outstanding than it did 1 year ago.
SBT has more shares outstanding than it did 5 years ago.
SBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SBT Yearly Shares OutstandingSBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SBT Yearly Total Debt VS Total AssetsSBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

SBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC19.84%
SBT Yearly LT Debt VS Equity VS FCFSBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SBT Yearly Current Assets VS Current LiabilitesSBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

SBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.24%.
The earnings per share for SBT have been decreasing by -40.76% on average. This is quite bad
SBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.07%.
SBT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -15.36% yearly.
EPS 1Y (TTM)-72.24%
EPS 3Y-55.43%
EPS 5Y-40.76%
EPS Q2Q%-77.29%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y-15.98%
Revenue growth 5Y-15.36%
Sales Q2Q%-11.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SBT Yearly Revenue VS EstimatesSBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
SBT Yearly EPS VS EstimatesSBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SBT is valuated quite expensively with a Price/Earnings ratio of 121.00.
Compared to the rest of the industry, the Price/Earnings ratio of SBT indicates a rather expensive valuation: SBT more expensive than 87.59% of the companies listed in the same industry.
SBT is valuated expensively when we compare the Price/Earnings ratio to 26.73, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 34.23 indicates a quite expensive valuation of SBT.
SBT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SBT is more expensive than 79.16% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SBT to the average of the S&P500 Index (34.61), we can say SBT is valued inline with the index average.
Industry RankSector Rank
PE 121
Fwd PE 34.23
SBT Price Earnings VS Forward Price EarningsSBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SBT is valued more expensive than 84.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 201.86
EV/EBITDA N/A
SBT Per share dataSBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.02
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Sterling Bancorp Inc

NASDAQ:SBT (3/31/2025, 8:00:02 PM)

After market: 4.88 +0.04 (+0.83%)

4.84

-0.04 (-0.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners26.89%
Inst Owner Change-6.14%
Ins Owners2.48%
Ins Owner Change-0.39%
Market Cap253.13M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-6.42%
Max Revenue beat(2)-2.83%
Revenue beat(4)0
Avg Revenue beat(4)-4.92%
Min Revenue beat(4)-7.35%
Max Revenue beat(4)-2.83%
Revenue beat(8)1
Avg Revenue beat(8)-4.4%
Revenue beat(12)2
Avg Revenue beat(12)-4.24%
Revenue beat(16)4
Avg Revenue beat(16)-3.14%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 121
Fwd PE 34.23
P/S 4.27
P/FCF 201.86
P/OCF 171.85
P/B 0.76
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)0.04
EY0.83%
EPS(NY)0.14
Fwd EY2.92%
FCF(TTM)0.02
FCFY0.5%
OCF(TTM)0.03
OCFY0.58%
SpS1.13
BVpS6.4
TBVpS6.37
PEG (NY)3.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.25%
ROE 1.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.19%
GM N/A
FCFM 2.12%
ROA(3y)-0.06%
ROA(5y)0.06%
ROE(3y)-0.55%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-46.39%
PM growth 5Y-29.96%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 20.07%
Cap/Sales 0.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 20.77%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC19.84%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.24%
EPS 3Y-55.43%
EPS 5Y-40.76%
EPS Q2Q%-77.29%
EPS Next Y40%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y-15.98%
Revenue growth 5Y-15.36%
Sales Q2Q%-11.28%
Revenue Next Year6.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.99%
OCF growth 3YN/A
OCF growth 5YN/A